These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 21038842)
21. Lipophilic oligonucleotides spontaneously insert into lipid membranes, bind complementary DNA strands, and sequester into lipid-disordered domains. Bunge A; Kurz A; Windeck AK; Korte T; Flasche W; Liebscher J; Herrmann A; Huster D Langmuir; 2007 Apr; 23(8):4455-64. PubMed ID: 17367171 [TBL] [Abstract][Full Text] [Related]
22. Solid lipid nanoparticles for parenteral drug delivery. Wissing SA; Kayser O; Müller RH Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768 [TBL] [Abstract][Full Text] [Related]
23. Method for quantifying the PEGylation of gelatin nanoparticle drug carrier systems using asymmetrical flow field-flow fractionation and refractive index detection. Zillies JC; Zwiorek K; Winter G; Coester C Anal Chem; 2007 Jun; 79(12):4574-80. PubMed ID: 17506521 [TBL] [Abstract][Full Text] [Related]
24. Multidimensional atomic force microscopy for drug discovery: a versatile tool for defining targets, designing therapeutics and monitoring their efficacy. Lal R; Arnsdorf MF Life Sci; 2010 Apr; 86(15-16):545-62. PubMed ID: 20359578 [TBL] [Abstract][Full Text] [Related]
25. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Liu CH; Wu CT; Fang JY Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495 [TBL] [Abstract][Full Text] [Related]
26. Molecular interaction and localization of tocotrienol-rich fraction (TRF) within the matrices of lipid nanoparticles: evidence studies by Differential Scanning Calorimetry (DSC) and Proton Nuclear Magnetic Resonance spectroscopy ((1)H NMR). Ali H; El-Sayed K; Sylvester PW; Nazzal S Colloids Surf B Biointerfaces; 2010 Jun; 77(2):286-97. PubMed ID: 20189780 [TBL] [Abstract][Full Text] [Related]
27. Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation. Marquele-Oliveira F; Santana DC; Taveira SF; Vermeulen DM; de Oliveira AR; da Silva RS; Lopez RF J Pharm Biomed Anal; 2010 Dec; 53(4):843-51. PubMed ID: 20634015 [TBL] [Abstract][Full Text] [Related]
29. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929 [TBL] [Abstract][Full Text] [Related]
30. Lipid membrane domain formation and alamethicin aggregation studied by calorimetry, sound velocity measurements, and atomic force microscopy. Oliynyk V; Jäger M; Heimburg T; Buckin V; Kaatze U Biophys Chem; 2008 May; 134(3):168-77. PubMed ID: 18342426 [TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil. Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496 [TBL] [Abstract][Full Text] [Related]
33. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405 [TBL] [Abstract][Full Text] [Related]
34. Fluorescence correlation spectroscopy for the characterisation of drug delivery systems. Delie F; Gurny R; Zimmer A Biol Chem; 2001 Mar; 382(3):487-90. PubMed ID: 11347898 [TBL] [Abstract][Full Text] [Related]
35. Lipid nanoparticles for improved topical application of drugs for skin diseases. Schäfer-Korting M; Mehnert W; Korting HC Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165 [TBL] [Abstract][Full Text] [Related]
36. Lipid oxidation deletes the nanodomain organization of artificial membranes. Muscatello U; Alessandrini A; Valdré G; Vannini V; Valdré U Biochem Biophys Res Commun; 2000 Apr; 270(2):448-52. PubMed ID: 10753645 [TBL] [Abstract][Full Text] [Related]
37. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system]. Wu HB; Huo DF; Jiang XG Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329 [TBL] [Abstract][Full Text] [Related]
38. Nanostructures by self-assembling peptide amphiphile as potential selective drug carriers. Accardo A; Tesauro D; Mangiapia G; Pedone C; Morelli G Biopolymers; 2007; 88(2):115-21. PubMed ID: 17154288 [TBL] [Abstract][Full Text] [Related]
39. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847 [TBL] [Abstract][Full Text] [Related]
40. Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis. Hammer MU; Brauser A; Olak C; Brezesinski G; Goldmann T; Gutsmann T; Andrä J Biochem J; 2010 Apr; 427(3):477-88. PubMed ID: 20187872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]